Publications

peer-reviewed papers

We have a proven track record of frequently publishing our innovation in internationally regarded, leading scientific journals.

2024





Editorial: lncRNAs: application in immunotherapy, radiotherapy, and chemotherapy


Source:
kahlert u 2024


Published on 2024-08-09




Glycometabolic reprogramming-induced XRCC1 lactylation confers therapeutic resistance in ALDH1A3-overexpressing glioblastoma


Source:
kahlert u 2024


Published on 2024-08-07




Hidden Appendicoliths and Their Impact on the Severity and Treatment of Acute Appendicitis


Source:
kahlert u 2024


Published on 2024-07-27




Unlocking Clinical Insights: Lymphocyte-Specific Protein Tyrosine Kinase Candidates as Promising Therapeutic Targets for Pancreatic Cancer Risk Stratification


Source:
kahlert u 2024


Published on 2024-06-05




mTORC1 regulates cell survival under glucose starvation through 4EBP1/2-mediated translational reprogramming of fatty acid metabolism


Source:
kahlert u 2024


Published on 2024-05-14




Nanoformulation of dasatinib cannot overcome therapy resistance of pancreatic cancer cells with low LYN kinase expression


Source:
kahlert u 2024


Published on 2024-05-13




Integrating a microRNA signature as a liquid biopsy-based tool for the early diagnosis and prediction of potential therapeutic targets in pancreatic cancer


Source:
kahlert u 2024


Published on 2023-11-10

2023





Transient receptor potential channels as predictive marker and potential indicator of chemoresistance in colon cancer


Source:
kahlert u 2023


Published on 2024-01-08




Editorial: Machine learning-assisted diagnosis and treatment of endocrine-related diseases


Source:
kahlert u 2023


Published on 2024-01-02




Seven oxidative stress-related genes predict the prognosis of hepatocellular carcinoma


Source:
kahlert u 2023


Published on 2023-12-14




The development of a hiPSC-based platform to identify tissue-dependencies of IDH1 R132H


Source:
kahlert u 2023


Published on 2023-12-12




Integrating a microRNA signature as a liquid biopsy-based tool for the early diagnosis and prediction of potential therapeutic targets in pancreatic cancer


Source:
kahlert u 2023


Published on 2023-11-10




Rapid, label-free classification of glioblastoma differentiation status combining confocal Raman spectroscopy and machine learning


Source:
kahlert u 2023


Published on 2023-11-06




Concept of a fully-implantable system to monitor tumor recurrence


Source:
kahlert u 2023


Published on 2023-09-29




Oxidative stress genes define two subtypes of triple-negative breast cancer with prognostic and therapeutic implications


Source:
kahlert u 2023


Published on 2023-07-31




Mendelian Randomization Analyses of Chronic Immune-Mediated Diseases, Circulating Inflammatory Biomarkers, and Cytokines in Relation to Liver Cancer


Source:
kahlert u 2023


Published on 2023-06-10




Effects of Dendrimer-microRNA Nanoformulations against Glioblastoma Stem Cells


Source:
kahlert u 2023


Published on 2023-03-29




Chromatin Regulator-Related Gene Signature for Predicting Prognosis and Immunotherapy Efficacy in Breast Cancer


Source:
kahlert u 2023


Published on 2023-02-09




Plasma extracellular vesicle messenger RNA profiling identifies prognostic EV signature for non-invasive risk stratification for survival prediction of patients with pancreatic ductal adenocarcinoma


Source:
kahlert u 2023


Published on 2023-02-04




Tacedinaline (CI-994), a class I HDAC inhibitor, targets intrinsic tumor growth and leptomeningeal dissemination in MYC-driven medulloblastoma while making them susceptible to anti-CD47-induced macrophage phagocytosis via NF-kB-TGM2 driven tumor inflammation


Source:
kahlert u 2023


Published on 2023-01-13

2022





MYCBP2 expression correlated with inflammatory cell infiltration and prognosis immunotherapy in thyroid cancer patients


Source:
kahlert u 2022


Published on 2022-12-30




The role of the ZEB1-neuroinflammation axis in CNS disorders


Source:
kahlert u 2022


Published on 2022-11-19




COL10A1 allows stratification of invasiveness of colon cancer and associates to extracellular matrix and immune cell enrichment in the tumor parenchyma


Source:
kahlert u 2022


Published on 2022-10-21




Preclinical Evidence for the Efficacy of CD79b Immunotherapy in B-cell Precursor Acute Lymphoblastic Leukemia


Source:
kahlert u 2022


Published on 2022-08-08




A Novel Extracellular Matrix Gene-Based Prognostic Model to Predict Overall Survive in Patients With Glioblastoma


Source:
kahlert u 2022


Published on 2022-07-05




Construction of ceRNA Networks Associated With CD8 T Cells in Breast Cancer


Source:
kahlert u 2022


Published on 2022-06-27




Meta-analysis on reporting practices as a source of heterogeneity in in vitro cancer research


Source:
kahlert u 2022


Published on 2022-06-20




Gender disparity regarding work-life balance satisfaction among German neuro-oncologists: a YoungNOA survey


Source:
kahlert u 2022


Published on 2022-05-31




In Vitro Validation of the Therapeutic Potential of Dendrimer-Based Nanoformulations against Tumor Stem Cells


Source:
kahlert u 2022


Published on 2022-05-28




CD133-Functionalized Gold Nanoparticles as a Carrier Platform for Telaglenastat (CB-839) against Tumor Stem Cells


Source:
kahlert u 2022


Published on 2022-05-28




Artificial Ovary for Young Female Breast Cancer Patients


Source:
kahlert u 2022


Published on 2022-04-04




Sensory Ion Channel Candidates Inform on the Clinical Course of Pancreatic Cancer and Present Potential Targets for Repurposing of FDA-Approved Agents


Source:
kahlert u 2022


Published on 2022-03-25




Progenitor cells derived from gene-engineered human induced pluripotent stem cells as synthetic cancer cell alternatives for in vitro pharmacology


Source:
kahlert u 2022


Published on 2022-03-25




Amphiphilic Triazine-Phosphorus Metallodendrons Possessing Anti-Cancer Stem Cell Activity


Source:
kahlert u 2022


Published on 2022-02-26




Multifaceted Analyses of Isolated Mitochondria Establish the Anticancer Drug 2-Hydroxyoleic Acid as an Inhibitor of Substrate Oxidation and an Activator of Complex IV-Dependent State 3 Respiration


Source:
kahlert u 2022


Published on 2022-02-15

For all complete listing of papers visit NCBI Pubmed: